Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 07-Jul-22 4:30 PM View:  | Taysha Gene Therapies, Inc. (TSHA) | 06-Jul-22 | Sale (Planned) | 8,956 | $3.79 | $33,943.20 | (2%) 539.54K to 530.59K | |
| 07-Jul-22 4:30 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 05-Jul-22 | Sale (Planned) | 3,905 | $3.51 | $13,706.50 | (< 1%) 543.45K to 539.54K | |
| 01-Jul-22 6:55 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 01-Jul-22 | Sale (Planned) | 23,923 | $3.53 | $84,448.20 | (4%) 567.37K to 543.45K | |
| 01-Jul-22 6:55 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 30-Jun-22 | Sale (Planned) | 13,892 | $3.72 | $51,678.20 | (2%) 581.26K to 567.37K | |
| 01-Jul-22 6:55 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 29-Jun-22 | Sale (Planned) | 12,324 | $3.81 | $46,954.40 | (2%) 593.59K to 581.26K | |
| 01-Jul-21 6:32 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 01-Jul-21 | Market Sale (Planned) | 19,706 | $21.12 | $416,191.00 | (3%) 613.29K to 593.59K | (< 1%) |
| 01-Jul-21 6:32 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 30-Jun-21 | Market Sale (Planned) | 20,076 | $21.79 | $437,494.00 | (3%) 633.37K to 613.29K | 3% |
| 01-Jul-21 6:32 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 29-Jun-21 | Market Sale (Planned) | 39,218 | $23.82 | $934,251.00 | (6%) 672.59K to 633.37K | 11% |
| 30-Sep-20 4:39 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 28-Sep-20 | Conversion | 3,844 | -- | -- | < 1% 668.75K to 672.59K | |
| 25-Sep-20 5:14 PM View: | Taysha Gene Therapies, Inc. (TSHA) | 23-Sep-20 | Grant | 668,745 | -- | -- | 100% 0 to 668.75K | |
| 07-Jun-19 4:42 PM View: | Audentes Therapeutics, Inc. (BOLD) | 05-Jun-19 | Payment of Exercise | 757 | $37.31 | $28,243.70 | (4%) 18.24K to 17.48K | < 1% |
| 15-May-19 4:42 PM View: | Audentes Therapeutics, Inc. (BOLD) | 13-May-19 | Option Exercise | 10,000 | $0.79 | $7,900.00 | 55% 18.24K to 28.24K | |
| 15-May-19 4:42 PM View: | Audentes Therapeutics, Inc. (BOLD) | 13-May-19 | Market Option Sale (Planned) | 10,000 | $36.98 | $369,798.00 | (35%) 28.24K to 18.24K | |
| 27-Feb-19 4:32 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Feb-19 | Option Exercise | 10,000 | $0.79 | $7,900.00 | 55% 18.24K to 28.24K | |
| 27-Feb-19 4:32 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Feb-19 | Market Option Sale (Planned) | 10,000 | $30.06 | $300,553.00 | (35%) 28.24K to 18.24K | |
| 08-Feb-19 5:25 PM View: | Audentes Therapeutics, Inc. (BOLD) | 06-Feb-19 | Grant | 17,500 | -- | -- | 2378% 0.74K to 18.24K | |
| 16-Nov-18 6:37 PM View: | Audentes Therapeutics, Inc. (BOLD) | 15-Nov-18 | Grant | 736 | $19.64 | $14,451.40 | 100% 0 to 0.74K | |
| 02-Oct-18 7:05 PM View: | Audentes Therapeutics, Inc. (BOLD) | 01-Oct-18 | Option Exercise | 10,000 | $0.79 | $7,900.00 | 213% 4.7K to 14.7K | |
| 02-Oct-18 7:05 PM View: | Audentes Therapeutics, Inc. (BOLD) | 01-Oct-18 | Market Option Sale (Planned) | 10,000 | $36.88 | $368,788.00 | (68%) 14.7K to 4.7K | 33% |
| 05-Jul-18 6:35 PM View: | Audentes Therapeutics, Inc. (BOLD) | 02-Jul-18 | Option Exercise | 10,000 | $0.79 | $7,900.00 | 200% 5.01K to 15.01K | |
| 05-Jul-18 6:35 PM View: | Audentes Therapeutics, Inc. (BOLD) | 02-Jul-18 | Market Option Sale (Planned) | 10,000 | $38.41 | $384,067.00 | (67%) 15.01K to 5.01K | 36% |
| 29-Mar-18 8:23 PM View: | Audentes Therapeutics, Inc. (BOLD) | 29-Mar-18 | Option Exercise | 7,800 | $0.79 | $6,162.00 | 100% 0 to 7.8K | |
| 28-Mar-18 9:12 PM View: | Audentes Therapeutics, Inc. (BOLD) | 27-Mar-18 | Option Exercise | 300 | $0.79 | $237.00 | 100% 0 to 0.3K | |
| 28-Mar-18 9:12 PM View: | Audentes Therapeutics, Inc. (BOLD) | 26-Mar-18 | Option Exercise | 1,900 | $0.79 | $1,501.00 | 100% 0 to 1.9K | |
| 28-Mar-18 9:12 PM View: | Audentes Therapeutics, Inc. (BOLD) | 26-Mar-18 | Market Option Sale (Planned) | 1,900 | $30.00 | $57,000.00 | (100%) 1.9K to 0 | 18% |
| 05-Dec-17 4:00 PM View: | Audentes Therapeutics, Inc. (BOLD) | 01-Dec-17 | Option Exercise | 8,000 | $0.79 | $6,320.00 | 100% 0 to 8.0K | |
| 05-Dec-17 4:00 PM View: | Audentes Therapeutics, Inc. (BOLD) | 01-Dec-17 | Market Option Sale (Planned) | 8,000 | $28.53 | $228,264.00 | (100%) 8.0K to 0 | 13% |
| 01-Sep-17 5:55 PM View: | Audentes Therapeutics, Inc. (BOLD) | 01-Sep-17 | Option Exercise | 8,000 | $0.79 | $6,320.00 | 100% 0 to 8.0K | |
| 01-Sep-17 5:55 PM View: | Audentes Therapeutics, Inc. (BOLD) | 01-Sep-17 | Market Option Sale (Planned) | 8,000 | $21.44 | $171,481.00 | (100%) 8.0K to 0 | (15%) |
| 29-Mar-18 8:23 PM View: | Audentes Therapeutics, Inc. (BOLD) | 29-Mar-17 | Planned Private Option Sale | 7,800 | $30.02 | $234,195.00 | (100%) 7.8K to 0 | |
| 28-Mar-18 9:12 PM View: | Audentes Therapeutics, Inc. (BOLD) | 27-Mar-17 | Planned Private Option Sale | 300 | $30.00 | $9,000.00 | (100%) 0.3K to 0 |